Powered by Smartsupp

Monthly Archives: July 2026

Does Mounjaro Cause Blood Clots?

Does Mounjaro Cause Blood Clots? Evidence and Safety Profile Written by Bolt Pharmacy Published on 10/6/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for managing type 2 diabetes mellitus. As with any medication, patients may have concerns about potential side effects, including whether Mounjaro causes blood clots. Understanding […]

Mounjaro and Cortisone Shot

Mounjaro and Cortisone Shot: UK Safety Guidance Written by Bolt Pharmacy Published on 14/4/2026 Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes management, whilst corticosteroid injections are widely used to treat joint inflammation and musculoskeletal conditions. Patients taking Mounjaro may require steroid injections for conditions such as […]

Does Mounjaro Cause Bleeding?

Does Mounjaro Cause Bleeding? UK Clinical Evidence and Guidance Written by Bolt Pharmacy Published on 15/7/2026 Does Mounjaro cause bleeding? This question concerns many patients prescribed tirzepatide for type 2 diabetes management. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus in adults. Whilst […]

Mounjaro and Alzheimer’s

Mounjaro and Alzheimer’s: Current Evidence and What Patients Should Know Written by Bolt Pharmacy Published on 24/7/2026 Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus in adults. Emerging research has explored potential links between diabetes medications and Alzheimer’s disease, given that type 2 diabetes increases […]

Best Time to Use Mounjaro

Best Time to Use Mounjaro: Dosing Schedule Guide Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a once-weekly injection licensed in the UK for type 2 diabetes and weight management. Many patients wonder about the best time to use Mounjaro to maximise its effectiveness. The good news is that Mounjaro offers considerable flexibility—it […]

Best Time of Day to Take Mounjaro for Weight Loss

Best Time of Day to Take Mounjaro for Weight Loss Written by Bolt Pharmacy Published on 3/7/2026 Many patients prescribed Mounjaro (tirzepatide) for type 2 diabetes wonder about the best time of day to take Mounjaro for weight loss. This once-weekly injectable medication, a dual GIP and GLP-1 receptor agonist, can be administered at any […]

Mounjaro and Vitamin C

Mounjaro and Vitamin C: Safety, Interactions, and Guidance Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a once-weekly injection licensed in the UK for treating type 2 diabetes. As a dual GIP and GLP-1 receptor agonist, it improves blood glucose control and promotes weight loss. Many patients wonder whether it is safe to […]

Does Mounjaro Expire? 

Does Mounjaro Expire? Shelf Life, Storage & Safety Guide Written by Bolt Pharmacy Published on 22/7/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes mellitus and weight management in adults with obesity or overweight with weight-related comorbidities. Understanding the shelf life of Mounjaro is crucial for ensuring your […]

Mounjaro Sweet Taste in Mouth

Mounjaro Sweet Taste in Mouth: Causes and Management Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus. Whilst gastrointestinal symptoms are well-documented side effects, some patients report experiencing a sweet taste in the mouth during treatment. Although […]

Mounjaro and Oesophagus Issues

Mounjaro and Oesophagus Issues: Symptoms, Risks and Management Written by Bolt Pharmacy Published on 22/7/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes management. Whilst the medication offers significant benefits for glycaemic control, concerns about Mounjaro and oesophagus issues have emerged amongst patients and healthcare […]